Our data support previously published results suggesting that hepatic nuclear receptors modulating genes controlling fatty acid and bile acid metabolism, including liver nuclear receptors PPARs, CAR, PXR and FXR, are inactivated in NASH patients [21,22,23,24]. The gene discussed is NR1I3; the disease is metabolic dysfunction-associated steatohepatitis.